Lanari, M., Venturini, E., Pierantoni, L., Stera, G., Gattinara, G., Esposito, S., et al. (2022). Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement. THE ITALIAN JOURNAL OF PEDIATRICS, 48, 1-10 [10.1186/s13052-021-01187-1].
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement
Villani A;
2022-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration an Italian inter-society consensus statement.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
642.61 kB
Formato
Adobe PDF
|
642.61 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
